vTv Therapeutics Inc. Made Headway
Fri, Feb 18, 2022 at 05:30 PM
vTv Therapeutics Inc. (VTVT:NASDAQ) jumped higher at $0.85, a gain of 19.2%. On Thu, Feb 17, 2022, VTVT:NASDAQ touched a New 2-Week Intraday High of $0.75. From Thu, Feb 03, 2022, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Fri, Sep 24, 2021 at $2.17 with a volume of 50M+, and its share price has been moving sideways in recent weeks.
About vTv Therapeutics Inc. (VTVT:NASDAQ)
vTv Therapeutics Inc is a biopharmaceutical company engaged in drug discovery and development. Its therapies are intended to treat diseases such as Alzheimer's and type-II diabetes.
Top 10 Gainers:
- Sky Harbour Group Corporation Class A (SKYH:NYSEMKT), 48.38%
- RISE Education Cayman Ltd (REDU:NASDAQ), 39.71%
- HOOKIPA Pharma Inc. (HOOK:NASDAQ), 24%
- Universal Security Instruments, Inc. (UUU:NYSEMKT), 23.81%
- Amplitude Inc. (AMPL:NASDAQ), 20.82%
- Maris-Tech Ltd. (MTEK:NASDAQ), 20.74%
- Cyngn Inc. (CYN:NASDAQ), 20%
- Karyopharm Therapeutics Inc. (KPTI:NASDAQ), 19.83%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 19.21%
- Flotek Industries, Inc. (FTK:NYSE), 16.3%